Omega-3: The Complete Guide

Omega-3 (EPA and DHA) are the two fish-oil fats with real clinical weight: they cut triglycerides, support brain and eye structure, and may lift mood. The story past that gets messy, and the form on the label matters more than most labels admit.

What it is

Omega-3 fats are long-chain polyunsaturated fats your body cannot make from scratch. Three forms matter. ALA (alpha-linolenic acid) comes from plants like flax and walnuts. EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) come from fatty fish, algae, and krill.

Your body converts ALA into EPA and DHA, but the rate is low. Most adults turn under 10% of ALA into EPA and under 1% into DHA (PMID:16828546). That is why fish oil, algal oil, and krill oil sit at the top of the omega-3 supplement shelf. They skip the conversion step.

DHA builds the membranes of brain cells and retinal cells. EPA shapes the inflammatory signals your body makes from arachidonic acid. Both fats are part of every cell in your body. When you run low, the cell membranes stiffen and the signals tilt toward inflammation (PMID:16841861).

Who needs more

You likely need more if you fit any of these profiles:

• You eat fatty fish less than twice a week.
• You follow a vegan or vegetarian diet without algal oil.
• You are pregnant or trying to conceive (DHA builds fetal brain).
• You have high triglycerides (over 150 mg/dL).
• You live with major depression or treatment-resistant depression.
• You eat a Western diet heavy in seed oils and processed food.

Modern Western diets push the omega-6 to omega-3 ratio past 15:1. The traditional human diet ran closer to 4:1 or lower (PMID:12442909). The shift pushes your inflammatory baseline up. Adding EPA and DHA pulls the ratio back without asking you to overhaul every meal.

Recommended daily intake

There is no formal RDA for EPA and DHA. The major bodies give different numbers, and they all sit in the same range.

• American Heart Association: 1 g per day combined EPA and DHA for people with coronary heart disease.
• EFSA: 250 mg per day combined EPA and DHA for healthy adults.
• WHO: 200 to 500 mg per day combined EPA and DHA.
• ISSFAL: 500 mg per day combined EPA and DHA.

For pregnancy, most groups push the DHA target to at least 200 mg per day on top of total omega-3 intake.

For therapy doses, the picture changes. Triglyceride lowering needs 2 to 4 g of combined EPA and DHA per day (PMID:31151218). Depression studies use 1 to 2 g of EPA per day on top of antidepressants (PMID:26688772). ADHD trials in children use 500 to 1,000 mg per day with EPA-heavy ratios (PMID:21961774).

Best food sources

Fatty cold-water fish lead by a long margin. A 100 g serving gives:

• Atlantic salmon (farmed): ~2,200 mg EPA + DHA
• Atlantic mackerel: ~2,500 mg EPA + DHA
• Sardines (canned in oil): ~1,400 mg EPA + DHA
• Anchovies: ~2,100 mg EPA + DHA
• Wild herring: ~1,700 mg EPA + DHA
• Albacore tuna: ~1,000 mg EPA + DHA
• Rainbow trout: ~1,000 mg EPA + DHA
• Oysters (Pacific): ~700 mg EPA + DHA

Plant ALA sources (your body converts a small fraction):

• Flax seeds (1 tbsp ground): ~2,300 mg ALA
• Chia seeds (1 tbsp): ~1,900 mg ALA
• Walnuts (1 oz): ~2,600 mg ALA
• Hemp seeds (1 tbsp): ~1,000 mg ALA

Algal oil sits in a category of its own. Microalgae produce DHA (and now EPA in newer strains) directly. It is the only vegan source that delivers EPA and DHA without the ALA conversion bottleneck.

Supplement forms compared

The form on the label drives both how well your body absorbs it and how stable the oil stays on the shelf. Four forms dominate.

Natural triglyceride (TG or rTG). EPA and DHA bound to a glycerol backbone, the same shape they have in fish. Bioavailability is the reference standard. Re-esterified triglyceride (rTG) is a TG form that has been concentrated, hydrolyzed to ethyl ester for purification, then re-esterified back to TG. One landmark crossover trial showed rTG absorption at 124% vs natural TG, ethyl ester at 73%, and free fatty acid at 91% (PMID:20439549). Most premium fish oils use rTG.

Ethyl ester (EE). EPA and DHA bound to ethanol instead of glycerol. The cheapest form. The synthetic ester bond is harder for pancreatic lipase to clip, which drops absorption. Taking EE with a high-fat meal narrows the gap (PMID:20439549). Most pharmacy-grade concentrates (including icosapent ethyl) are EE.

Phospholipid (krill oil). EPA and DHA bound to phosphatidylcholine, the same backbone your cell membranes use. A 2024 network meta-analysis of 26 RCTs found krill oil delivers more EPA and DHA per gram than fish oil at doses under 2 g per day. At higher doses, fish oil catches up (PMID:39741957). Krill oil also carries astaxanthin, a natural antioxidant that protects the oil from going rancid in the capsule.

Algal oil. Vegan EPA and DHA grown in tanks of microalgae. Older algal strains were mostly DHA; newer strains (Schizochytrium) now deliver both. Bioavailability matches or beats fish oil (PMID:24505408). Zero ocean contaminants. The downside is cost per gram, which still runs 30 to 60% higher than fish oil.

EPA:DHA ratios for different goals:

• High EPA (3:1 or higher EPA:DHA, 1-2 g EPA per day): mood, depression, inflammation
• Balanced (1:1 to 2:1): general health, cardiovascular support
• DHA-dominant (1:2 or higher DHA:EPA): pregnancy, infant cognitive development, retinal health

Evidence-graded benefits

Strong evidence

• Triglyceride lowering. At 2 to 4 g per day of combined EPA and DHA, triglycerides drop 20 to 30%. The effect is dose-dependent and shows up in every major meta-analysis (PMID:31151218).
• Acute alertness and focus from coffee — that's caffeine, not omega-3. Strike that.
• Fetal and infant brain development. DHA crosses the placenta into the fetal brain and breast milk. Adequate maternal DHA correlates with better visual acuity and slightly higher cognitive scores in children at 4 years (PMID:18065438).

Moderate evidence

• Depression (high-EPA formulations). Meta-analyses agree on a small-to-moderate effect for major depression when EPA makes up at least 60% of the EPA + DHA dose, at 1 to 2 g of EPA per day. Pure DHA shows no benefit (PMID:20439549, PMID:31383846). EPA changes membrane signaling in ways DHA does not.
• Reduction of secondary cardiac events. Post-MI patients taking omega-3 see modest reductions in cardiac death in some trials, but the effect has weakened as background statin use has risen.

Emerging evidence

• ADHD adjunct in children. A meta-analysis of 10 RCTs in 699 children found small but significant improvements in ADHD symptoms with EPA-heavy doses of 500 mg to 1 g per day over 16 to 24 weeks (PMID:21961774). Not a replacement for stimulants; an add-on with low risk.
• Dry eye disease. A 2023 meta-analysis of 19 RCTs (4,246 patients) showed improvement in tear break-up time and Schirmer test scores with omega-3 supplementation. A separate large RCT in moderate-to-severe dry eye was negative, so the population matters (PMID:38002640).

Disputed evidence

• Primary cardiovascular prevention. Three landmark trials disagree. VITAL (2019, 25,871 healthy adults, 1 g EPA + DHA per day) showed no reduction in major cardiovascular events (PMID:30415637). STRENGTH (2020, 13,078 high-risk patients, 4 g per day of EPA + DHA carboxylic acid) was stopped early for futility, with no benefit vs corn oil placebo and a small increase in atrial fibrillation (PMID:33190147). REDUCE-IT (2018, 8,179 high-risk patients on statins, 4 g per day of pure EPA as icosapent ethyl) cut major cardiovascular events by 25% vs mineral oil placebo (PMID:30415628).

The REDUCE-IT vs STRENGTH gap drives a real debate. Three explanations remain in play:

1. EPA alone is more cardio-protective than EPA + DHA combinations.
2. The mineral oil placebo in REDUCE-IT raised inflammatory and lipid markers in the control arm, inflating the apparent benefit. A 2024 reanalysis showed mineral oil controls saw rises in LDL, hs-CRP, IL-6, oxidized LDL, and Lp(a) that the corn oil controls in STRENGTH did not (DOI:10.3389/fnut.2024.1490953).
3. The icosapent ethyl dose hits a different EPA blood-level threshold than mixed formulas.

The honest answer: general-population omega-3 from food and modest supplements does not reduce heart attacks in healthy people. High-risk patients on statins with elevated triglycerides may benefit from prescription EPA. The mineral oil controversy is real and unresolved.

How to take it

• Take omega-3 with a meal containing fat. Lipase needs fat in the gut to work on the oil.
• Refrigerate the bottle after opening. Cold slows oxidation. Frozen capsules also blunt the fish burp.
• Split high doses (over 2 g per day) across two meals. Better tolerance, more stable blood levels.
• Check the TOTOX (total oxidation) value if the brand publishes it. Aim for under 26. Higher numbers mean rancid oil, which can do more harm than good (PMID:25960245).
• Look for third-party testing (IFOS, USP, NSF). Heavy metals and PCBs concentrate in fish; the supplement should not.
• Pair with vitamin E. Many fish oils already include a touch of mixed tocopherols to slow oxidation in the capsule.

If you fish-burp, switch from EE to TG form, or move to enteric-coated capsules, or split the dose.

Side effects and upper limit

EFSA set a safe upper limit at 5 g per day of combined EPA + DHA from supplements (PMID:22730887). The FDA tolerates up to 3 g per day from supplements in the general population. Above these levels:

• Bleeding time lengthens. Bruising rises slightly. Clinically relevant bleeding stays rare at 3 to 4 g per day in healthy adults (PMID:33784348).
• Atrial fibrillation risk rises at high doses (over 4 g per day) in patients with cardiovascular disease (PMID:33190147, PMID:34813218). The signal is real in both REDUCE-IT and STRENGTH.
• Mild GI upset, loose stools, and reflux.
• Fish burp. Almost universal with low-quality EE forms.

Oxidized fish oil is its own risk. Capsules left in heat or past their date can carry oxidation products that promote, rather than fight, inflammation.

Interactions

• Anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel). Both omega-3 and these drugs reduce clotting. Recent meta-analyses show typical doses (under 3 g per day) do not raise major bleeding in patients on warfarin, but monitoring INR around dose changes is still standard care (PMID:31177579).
• Statins. No clinically meaningful interaction. Omega-3 and statins work on different lipid pathways and are routinely combined.
• Blood pressure medications. Omega-3 has a small additive blood-pressure-lowering effect. Mild benefit, no warning required.
• Vitamin E. Synergistic. Vitamin E protects EPA and DHA from oxidation in the body and the capsule (PMID:15798090).
• Curcumin and CoQ10. Both pair well with omega-3 for cardiovascular and anti-inflammatory goals.

Myths debunked

"More is always better." MIXED. Below the EFSA upper limit, more EPA + DHA delivers more triglyceride reduction. Past 4 g per day, the curve flattens for most outcomes and the atrial fibrillation signal grows. Oxidation risk grows too. Dose by your goal, not by maximalism.

"Krill oil is always better than fish oil." FALSE. The phospholipid form gives krill an absorption edge per gram at doses under 2 g per day. Above 2 g per day, fish oil delivers more EPA + DHA per dollar and matches krill on blood-level outcomes (PMID:39741957). Picking between them is a budget and dose decision, not a quality decision.

"Vegan omega-3 is inadequate." FALSE. ALA conversion to EPA and DHA is poor, but algal oil delivers EPA and DHA directly. A 2014 RCT showed algal oil matched fish oil in raising the omega-3 index (PMID:24505408). The price gap is real; the biology gap is not.

"Fish oil cures depression." OVERSTATED. EPA-heavy omega-3 (over 60% EPA, 1 to 2 g EPA per day) is an evidence-based adjunct for major depression, not a stand-alone treatment. The effect size is small to moderate (PMID:31383846). Pure DHA shows nothing for mood.

"Higher omega-3 index means better brain." PARTIALLY TRUE. Observational data link a higher omega-3 index (sum of EPA + DHA in red blood cells) to slower cognitive decline. RCT data for primary cognitive prevention in healthy older adults are mixed. Sound bet for brain structure, weak bet for cognitive reversal once decline starts.

FAQ

How long until I notice effects? Triglyceride changes show up at 4 to 8 weeks. Mood effects (when they show up) emerge at 8 to 12 weeks. Omega-3 index plateaus in red blood cells at around 3 to 4 months.

Fish oil or krill oil? For doses under 2 g per day and a tight budget, krill gives slightly better absorption per gram and includes astaxanthin. For 2 g per day or more, high-quality rTG fish oil is more cost-effective. Both work.

Can I get enough from food alone? Yes, if you eat fatty fish twice a week. The American Heart Association considers two servings of fatty fish per week roughly equivalent to 250 to 500 mg per day of combined EPA and DHA.

What is the omega-3 index? The percentage of EPA + DHA in your red blood cell membranes. Above 8% sits in the protective range; under 4% sits in the high-risk range (PMID:15531325). Some labs offer at-home tests.

Does ALA from flax replace fish oil? No. Conversion is too low. ALA is its own essential fat with its own (mostly cardiovascular) benefits, but it does not raise your EPA and DHA levels enough to count.

Should I take it during pregnancy? DHA at 200 mg per day or more is the standard recommendation through pregnancy and lactation. Mercury-tested fish oil and algal oil are both fine. Avoid high-mercury fish (large tuna, king mackerel, swordfish).

Top products from our catalog

Browse all 57 omega-3 supplements in the MoodStack catalog at the bottom of this page. We score products on dose adequacy, form bioavailability, brand transparency, and contaminant testing. The highest-rated products use rTG or phospholipid forms, publish third-party test results (IFOS or USP), and hit a useful EPA + DHA dose per serving (1 g or more).

This article is for general education and not medical advice. Talk to a licensed clinician before changing supplements, especially if you take anticoagulants or are pregnant.